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Abstract
Background: Malassezia commensal yeasts along with multitude of antigens have been found to be associated
with various skin disorders including Pityriasis versicolor (PV). Amongst them Mala s1, a 37 kDa protein has been
proved to be a major allergen reacting with a large panel of sera. However, there exists no therapeutic alternative
to combat such problems in form of plant based natural compounds. The purpose of this study is in the first
place, to determine the anti-Malassezia activity of Nyctanthes arbor-tristis L. (NAT) ethanolic leaf extract through
turbidimetric growth curves, disruption of plasma membrane and secondly, it aims to present in silico validation
of its active constituents over Mala s1a novel allergen.
Methods: The antifungal susceptibility 50 % ethanolic extract of NAT was determined by broth microdilution
method according to CLSI guidelines. Further MICs and IC50 were determined spectrophotometrically using the
software SoftMax® Pro-5 (Molecular Devices, USA). Active constituents mediated disruption of plasma membrane
was studied through flowcytometry by permeabilization of fluorescent dye Propidium Iodide (PI). Antioxidant
activity of the extract was determined using the DPPH stable radical. Molecular validation of fungal DNA from the
extract was observed using PCR amplification. In silico analysis of its active constituents over Mala s1 was performed
using HEX software and visualized through Pymol.
Results: The anti-Malassezia potential of NAT leaf extracts reflected moderate MIC 1.05 μg/μl against M. globosa, while
least effective against M. restricta with MIC 1.47 μg/μl. A linear correlation coefficient R2 = 0.866 was obtained in case of
M. globosa while minimum was observed in M. restricta with R2 = 0.732. The flow cytometric data reveal ~ 75 % cell
death when treated with active constituents β-Sitosterol and Calceolarioside A. The docking confirmations and the
interaction energies between Mala s1 and the active constituents (β-Sitosterol and Calceolarioside A) from extracts
showed an effective binding which suggests Mala s1 as efficient allergen for site specific targeting.
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Conclusions: This study revealed that Nyctanthes arbor-tristis L. (NAT) extracts possess high anti-Malassezia potential
which is driven mainly by disruption of plasma membrane. Also in silico validation and molecular modeling studies
establishes Mala s1 as a novel allergen that could be a potential target in disease treatment. Our results would also
provide a foundation for the development of new therapeutic approach using NAT extract as lead compound with
high antioxidant property as an added trait for skin care.
Keywords: Nyctanthes arbor-tristis L. (NAT), Anti-Malassezia susceptibility, AUGC, Flow cytometry, Mala s1, Molecular
docking
Background
Malassezia species (formerly Pityrosporum ovale) are
exclusively the single eukaryotic member that forms a
part of the resident skin microflora of human and
other warm-blooded vertebrates with wide intra-
species diversity [1, 2]. This intra-species diversity
could be attributed to fungal evolution due to ecol-
ogy, host adaptation, and pathogenicity [3]. These are
opportunistic yeasts requiring predisposing environ-
mental circumstances such as temperature and
humidity, patient immune status, and genetic susceptibil-
ity [4]. Malassezia spp. are associated with different super-
ficial pathogenesis, including Pityriasis versicolor (PV),
Seborrheic dermatitis (SD), folliculitis as well as nosoco-
mial bloodstream infection in pediatric care units [5, 6].
They have a species-specific ability to interact with
cells and structures associated with skin, e.g. various
keratinocyte subpopulations. Cell lineages involved in
immune functions, including Antigen-presenting
Dendritic Cells, Pattern Recognition Receptors (PRRs),
Macrophages, Eosinophils and Neutrophils have also
been found to be affected by Malassezia spp. [7, 8].
Moreover, the host interaction with Malassezia yeast
can stimulate sensitization; elicit IgE production and
T-cell reactivity. Malassezia extract contains a wide
range of IgE binding proteins [9], however, variations
in allergenic content exist. Experimental findings
establish Mala s1 as a major allergen in skin disorders
with 58 % IgE binding frequency [10, 11]. Mala s1 is of
particular importance since it is localized in the cell wall
and therefore, is easily accessible for the interplay with
human innate and acquired immune system.
Many azoles derivatives are frequently used as
preventive measures against fungal infections [12, 13].
However, in response to synthetic antifungal, develop-
ment of resistant strains [14] and recapitulation of the
disease symptoms with severe side effects have import-
ant implications in health care [15]. According to Jesus
et al. [16] Malassezia spp. was found to be susceptible
to various azole derivatives with MICs ranging from 0.01
to 4 μg/ml. However, isolates generated through in-vitro
induction of resistance against fluconazole exhibited
increased MICs ranging from 64 to 128 μg/ml. These
strains were also found to be resistant against other
azole derivatives. In recent years, natural products have
been used in the discovery and development of drugs
[17]. Complementary and Alternative medicines (CAM)
approaches and interventions have been found to exert
their effect in boosting immune response and reducing
pathogen-associated symptoms [18]. In recent years they
have become important molecular tools for identifica-
tion of various cellular interactions because they are
capable of binding specific target proteins and then
interfere with their metabolism.
In India, hundreds of botanicals have traditionally
been used as therapeutic alternative for majority of
diseases. Many of these plants are commonly used even
today. In support of this fact recently, we reported
ethanolic extract of lichen Cladia to be effective against
Malassezia spp. [19]. Nyctanthes arbor-tristis L. (NAT)
commonly known as Night Jasmine (Parijatha) is one
amongst them. The decoction of leaves is extensively
used by Ayurvedic physicians for the treatment of
arthritis, obstinate sciatica, malaria, intestinal worms
and as a tonic, cholagogue and laxative [20]. In
addition, analgesics, antipyretic along with ulcerogenic
potency have also been observed [21]. The plant
extract has also been defined to possess potent
immunomodulatory activity through strong sti-
mulation of antigen-specific and non-specific immun-
ity as shown by increased humoral and delayed type
hypersensitivity responses [22]. A water-soluble frac-
tion of the ethanol extract elicits significant anti-
inflammatory activity against acute inflammatory
oedema produced in in-vivo models [23]. The 50 %
ethanolic seed and root extracts of NAT also show
immunomodulatory activity in systemic candidiasis
infections in mice [24]. Active constituents like
calceolarioside A and β-sitosterol from leaves have
been reported as an efficient anti-inflammatory, anti-
leishmanial and anticancer compound [25]. Thus,
considering the evidence of antimicrobial and immu-
nomodulatory potential, it would be interesting to
study if the plant ethanolic extract is somehow
involved in the modulation of infection caused by
Malassezia. Anti-Malassezia susceptibility was studied
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using CLSI broth microdilution method which has
recently been accepted widely [26]. Moreover, the
interaction of Malassezia yeast with the skin results
in exhaustive damage to skin baarier and its struc-
tures [27]. The dermal reconstruction is attributed to
efficient synchronization of skin cells and immu-
nomodulatory factors [28]. Accumulated research
indicates effective role of antioxidant potency of
botanicals in treating degenerative diseases [29, 30].
Thus, in order to address the problem of skin damage
caused in PV, ethanolic NAT extract has also been
assessed for its anti oxidant capacity through DPPH
(1,1-Diphenyl-2-picryl-hydrazyl) assay.
Interestingly, Mala s1 has been spotted as the major
allergen in the yeast and its capacity to stimulate the
immune system is well documented, but its antigenic-
ity has not yet been elucidated. Despite the fact that
its 3D structure and localization in the cell wall have
been elaborated, their functional details are still an
enigma. Therefore, in the current study, we took a
top-down approach to identify the antifungal potential
of NAT leaf extract through broth microdilution assay
and PCR. We systematically monitored the growth pat-
terns of the yeast to establish the antifungal susceptibility
of the plant extract. We also studied whether plant
extract and the active constituents could bring about
changes in cell membrane integrity by measuring
Propidium Iodide (PI) influx through flow cytometer.
Taking advantage of exclusive prior knowledge of
NAT and its active constituents, we systematically
screened two molecules by virtue of their antimicro-
bial ability (β-Sitosterol and Calceolarioside A) and




The fresh leaves of Nyctanthes arbor-tristis L. (NAT) were
collected from Roxburgh garden, University of Allahabad,
India. The plant was identified and authenticated from
Botanical Survey of India (BSI), Allahabad and voucher
specimen was kept in Duthie Herbarium, Dept. of
Botany, University of Allahabad with reference number
BPL/NAT/1009.
Microorganisms
Four strains M. furfur 1878; M. restricta 7877; M.
globosa 7966 and M. sympodialis 9974 were procured
from Central Bureau voor Schimmelcultures (CBS)
Fungal Biodiversity Centre, Institute of the Royal
Netherlands Academy of Arts and Sciences (KNAW),
Netherlands (Fig. 1).
Preparation of ethanolic extract
Freshly collected leaves of Nyctanthes arbor-tristis L.
(NAT) were cut into pieces and shade dried at room
temperature. They were then minced using mortar. The
processed sample was mixed in 50 % ethanol (1:5) for
24 h. The extracts were finally filtered and concentrated
using Rotatory evaporator (Buchi type) and stored at 4 °C.
Antifungal susceptibility test
The antifungal activity of 50 % ethanolic extract of
NAT was determined using broth microdilution in
96-well flat bottom microtiter plates according to
CLSI guidelines [31, 32]. Briefly, ethanolic extract of
NAT was dissolved in 5–10 % DMSO to obtain a
stock solution of 50 μg/μl, which was then serially
diluted 1:10 in medium in order to attain final
Fig. 1 Standard strains of Malassezia sp. a M. furfur b M. restricta c M. globosa d M. sympodialis. Cultures were procured from Royal Netherlands
Academy (Netherland) and grown in Modified Leming and Notman Agar (MLNA) and were visualized microscopically (a to d) e Scanning
electron micrograph (SEM) of Mala s1 allergen producing Malassezia sympodialis (Magnification 20,000X, Pressure 0.976 Torr, WD 11.8 mm)
Mishra et al. BMC Complementary and Alternative Medicine  (2016) 16:114 Page 3 of 14
concentration ranging from 0.02 to 2.5 μg/μl. Each
well was subsequently filled with 100 μl of inoculum.
The initial concentration of inoculum was 1x106cells/ml
(adjusted according to 0.5 McFarland) in liquid media
BPL5O (Patent application no. DEL/546/2012) [33, 34].
The plates were incubated at 35 ± 2 °C in wet cham-
ber for 72 h and experiments were conducted in
triplicate.
Quantification of fungal growth
After 12 h of incubation, the optical density of the
microtiter plates was recorded spectrophotometrically
at 530 nm using SpectraMaxplus384 (Molecular Devices,
USA). The process was repeated after every 12 h of incu-
bation and continued till 72 h. The changes in OD over
time were used to generate growth curves at each drug
concentration against the control. The normalized OD of
the extract treated wells (OD obtained after subtraction of
the background OD) was used for the generation of tur-
bidimetric growth curves. Percentage of growth inhibition
at each drug concentration was calculated using the
formula:
% growth ¼ OD530 of wells containing the extract
OD530 of the extract free well
 100
Area under growth curve (AUGC) analysis
AUGC was calculated and integrated using SoftMax®
Pro-5 (Molecular Devices, USA). Potential differences in
the OD530 among individual wells were accounted for by
subtracting the initial OD530 from the values measured
during the 72 h incubation, yielding net OD530 changes
for each well. The curve was generated between AUGC
vs NAT leaf extract concentration (log transformed) and
a linear regression analysis was performed in MS Excel.
Determination of minimum inhibitory concentrations (MICs)
MICs were determined spectrophotometrically using the
software SoftMax® Pro-5 (Molecular Devices, USA). For
the NAT extract, the MIC was determined as the lowest
drug concentration showing ≥80 % growth inhibition
compared with the growth in the extract-free well. Each
test was performed for triplicates.
Determination of minimum fungicidal concentration (MFC)
MFC was defined as the lowest concentration of the
plant extract at which 99.99 % or more of the initial in-
oculum was killed. 100 μl aliquot of inoculum was taken
aseptically from those wells that did not show turbidity
and was poured on Modified Leming and Notman Agar
(MLNA) agar plates followed by incubation for 4 days at
35 ± 2 °C. Absence of growth reflected that the concen-
tration was cidal. The number of surviving organisms
was determined by viability counts. All tests were per-
formed for triplicates.
Molecular validation of fungal DNA from the extract
using PCR amplification
Cells from the wells were collected for DNA extraction
using AccuPrep® Genomic DNA Extraction Kit (Bioneer,
South Korea) according to the manufacturer’s protocol.
PCR was performed using 4X Universal Hot Start PCR
Premix (Professional Biotech India Ltd., India). The
thermal cycler conditions followed were: Initial PCR
activation at 95 °C for 15 min followed by 45 cycles of
denaturation at 94 °C for 15 s, annealing at a 5 °C below
the Tm of primers for 30s and extension of 30 s at 72 °C
and final extension at 72 °C for 10 min. Primers were
designed from 26S rDNA and ITS regions of all four
Malassezia species. The primer sequences were (F) 5′
ATCCTTTGCAGACGACTTGA 3′ and (R) 5′TGCTT
AACTTCGCAGATCGG 3′. PCR products were run on
1.2 % agarose gel containing ethidium bromide and then
viewed on Gel Documentation system (Vilber Lourmate,
France) and analyzed using VISION-CAPT software
(v14.3). Molecular weight marker (0.5 μg) containing a
defined quantity of each band was loaded.
Flow cytometric analysis for plasma membrane
permeabilization
The membrane permeability of fungal cells after treatment
with the active constituents (Calceolarioside and β Sitos-
terol) was measured by Propidium Iodide (PI) influx
through flow cytometer. The two active constituent’s β-
Sitosterol (Product No. S1 270, CAS No. 83-46-5) and
Calceolarioside A (Product No. SMB00246, CAS No.
84744-28-5) were procured from Sigma-Aldrich. Cells
were incubated with the two compounds at concentra-
tions 0.31 and 0.62 μg/μl for 12 h at 35 ± 2 °C. Following
incubation, cells were washed and resuspended in PBS
and subsequently stained with PI (30 μg/ml) for 20 min.
The cells were analyzed by BD Accuri C6 (Becton
Dikinson, San Jose, CA, USA). Intrinsic parameter (SSC-
A) and fluorescence in FL-2 channel for PI were acquired
and recorded over logarithmic scale. The changes in
treated cells were compared with untreated cells as well as
with cells treated with whole NAT extract.
Diphenylpicryl-hydrazyl (DPPH) radical scavenging capacity
The antioxidant activity of the extract was determined in
terms of hydrogen donating or radical scavenging ability
using the DPPH stable radical. The assay was performed
according to Brad-Willam et al. [35] with slight modifica-
tions. DPPH cation solution was prepared by adding
400 μM DPPH in 0.2 M MES buffer (pH 6) and 20 % (v/v)
Ethanol in equal volumes. 10 μg/μl of plant extract was
prepared in 5–10 % of DMSO. The stock solution was
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further diluted to 2.5 μg/μl in 96 well Microtitre plate.
DPPH cation solution was pipetted in each well and
mixed with plant extract (3:1) and incubated in dark at
room temperature for 20 min. Absorbance was recorded
spectrophotometrically by SpectraMaxplus384 at 517 nm.
Radical scavenging activity of the samples was expressed
as IC50 which is the concentration of the sample required
to inhibit 50 % of DPPH concentration. Ascorbic acid was
taken as standard anti-oxidant with IC50 0.5 μg/μl. The
percent inhibition was taken into account by its FRSA
count and calculated by the following formula:
% Inhibition ¼ O:D: blank‐O:D: sample
O:D: sample
 100
In-silico analysis and molecular modeling
β-Sitosterol and Calceolarioside A were obtained from
Pubchem of NCBI (http://pubchem.ncbi.nlm.nih.gov/) in
SD (structural data) format and converted to 3D struc-
ture using Pc3D Molecular Viewer (Fig. 2).
Crystal structure of Mala s1 allergen of Malassezia
sympodialis (PDB id- 2P9W) was retrieved from Protein
Data Bank (www.rcsb.org). The active binding sites of
the allergen were determined using Q-site identifier [36].
Around 10 sites were identified by analysing clusters of
energetically favorable methyl binding sites to predict
the ligand binding sites [37]. The PDB structures after
molecular dynamics and simulations were submitted to
HEX server [38]. The parameters used for the docking
process were correlation type-shape only, calculation de-
vice- GPU, number of solutions-100, FFT mode -3D fast
lite, grid dimension-0.6, receptor range-180, ligand range-
180, twist range-360, distance range-40. HEX works on
FFT correlation using spherical polar coordinates and
Gaussian density representation of protein shape. The re-
sults were compared on the basis of docking energy and
the structures were visualized through Pymol
(www.pymol.org).
Statistical analysis
All experiments were independently repeated in tripli-
cates. Results were expressed as mean ± Standard error
(SE). Linear Regression analysis was performed to
determine the correlation between AUGC and drug con-
centration of different Malassezia spp. The statistical ana-
lysis was performed in MS Excel.
Results
In-vitro antifungal susceptibility using turbidimetric
growth analysis
The growth curves generated spectrophotometrically
revealed variation in shape as well as growth rate with
respect to extract concentrations, however, a consistent
pattern was observed among the replicates. AUGC, as
an important marker for pharmaco-dynamic study of in-
vitro antifungal susceptibility, was also studied. Growth
curves of M. furfur, M. restricta, M. globosa and M.
sympodialis represented for 0–72 h at different con-
centrations of NAT extract are shown in Figs. 3a-i, b-i and
4a-i, b-i. Although, each growth phase could have been
affected by each concentration in various ways (viz., cell
wall or membrane damage, signaling blockage damage
etc.), the most obvious change reflected was the shift of
the growth curve towards right in response to the increas-
ing concentration of the extract. Experiments were per-
formed with four fungal strains over a similar dose range
and conditions. Since, the results represent an undeviating
pattern for all tested strains, the first result set of M. furfur
was discussed and analyzed. The tlag phase in all the
growth curves stretched till 24 h that exhibited no specific
changes in OD as well as AUGC values that were lower
than 2 % of the maximal (data not shown) at all concen-
trations. However, significant changes were observed dur-
ing the exponential growth phase of fungus. The control
represented rapid increase in OD and about 76 % increase
in AUGC was reached. The extract concentration ranging
from 0.02 to 2.5 μg/μl exhibited a down regulation of OD
values, thereby reducing the AUGC from 52 % for
0.02 μg/μl to 28 % for 1.25 μg/μl. The stationary phase re-
corded no prominent changes in OD and AUGC, thereby
indicating fungal growth inhibition.
In-vitro antifungal susceptibility for determination of
MICs and MFCs
The extract showed moderate MIC of 1.05 μg/μl against
M. globosa, while least effective against M. restricta with
their MIC of 1.47 μg/μl (Table 1). However, ethanolic
Fig. 2 Chemical structures a β-Sitosterol (Pubchem ID-222284); b Calceolarioside A (Pubchem ID-5273566)




























































































Fig. 3 Graphical representation of the growth of a M. furfur-1878 and b M. restricta-7877 against NAT leaf extract concentrations of 0.02 ( ),
0.078 ( ), 0.313 ( ), 1.25 ( ), and 2.5 ( ) μg/μl with control ( ). (a-i) and (b-i) Changes in OD530 over time. ODs were normalized for
each growth curve by subtracting the background OD at each time point. (a-ii) and (b-ii) % growth inhibition over concentration. Data represent

























































































Fig. 4 Graphical representation of the growth of a M. globosa-7966 and b M. sympodialis-9974 against NAT leaf extract concentrations of 0.02
( ), 0.078 ( ), 0.313 ( ), 1.25 ( ), and 2.5 ( )μg/μl with control ( ). a-i and b-i Changes in OD530 over time. ODs were
normalized for each growth curve by subtracting the background OD at each time point. a-ii and b-ii % growth inhibition over concentration.
Data represent mean ± standard error of three replicates and * represents MIC
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NAT extract exhibited MFC at a higher concentration
(3.12 μg/μl) against all four tested strains (Fig. 1). The
percent growth inhibitions of all four tested strains are
expressed as Figs. 3a-ii, b-ii and 4a-ii, b-ii. A curve was
plotted between extract concentration and percent growth
inhibition. The graphic was complemented with a linear
regression coefficient to analyze correlation between
extract concentrations and percent inhibition. Significant
correlation was found between extract concentrations and
percent growth inhibition with a maximum R2 = 0.975 for
M. restricta. Moreover, similar correlations were observed
with other groups of tested strains suggesting that the
data may be useful for further primary modeling of
antifungal extract.
The linear relationship resulted when the AUGC data
were plotted as a function of antifungal extract (both log
transformed) concentrations over the working range of
the assay (0.02 to 2.5 μg/μl). The correlation coefficient
between the AUGC and concentration of antifungal ex-
tract is expressed in Fig. 5. A maximum correlation coef-
ficient was observed for M. globosa with R2 = 0.866 and
minimum was observed in case of M. restricta with R2 =
0.732. Intermediate values were observed for M. sympo-
dialis (R2 = 0.804) and M. furfur (R2 = 0.837). AUGC was
highly correlated with the applied concentrations of
extract and was found to decrease significantly with the
increasing concentration. An overlapping correlation
pattern was observed for all the tested strains that con-
verged at the same point indicating that MIC values fall
under the same concentration range.
Molecular validation of fungal DNA treated with extract
using PCR amplification
The preliminary evidence of antifungal susceptibility was
further validated by PCR amplification. The gel image
revealed low band intensities of amplicons in treated
DNA samples against comparison to the control sam-
ples. In the present study, results, therefore, reflect a
good relationship between MIC and the DNA expres-
sion, suggesting that NAT extract could deplete fungal
DNA thus restricting fungal growth (Fig. 6).
Impact of active constituents on plasma membrane lesion
using flowcytometry
To evaluate the effect of active constituents over plasma
membrane, we measure the PI influx in cells was mea-
sured by flow cytometer. Both β-Sitosterol and Calceo-
larioside A treatment has shown an increase in PI influx.
Figure 7a reveals no internalization of PI that represents
cells with intact plasma membrane. However, a dose
dependent response has been observed in active
constituent treated cells. ~42.2 and 74.3 % cells have
been found to show PI internalization due to lesions in
plasma membrane when treated with 0.31 and 0.62 μg/μl
of β-Sitosterol (Fig. 7c, d). Furthermore, similar concentra-
tions of Calceolarioside A resulted in ~60.1 and 83.2 %
cell death respectively (Fig. 7e, f ). The whole NAT extract
also showed ~75.1 % cell death but with a higher dose
concentration that corresponds to the MIC value
(1.31 μg/μl) (Fig. 7b).
Antioxidant activity
The leaf extract of NAT showed good antioxidant activity
using Diphenylpicryl-hydrazyl (DPPH) radical scavenging
capacity, which was clearly reflected in the results showing
IC50 of 2.5 μg/μl. The reference standard used was Ascor-
bic acid with IC50 10 μg/ml. The efficiency of plant leaf
extract as potential antioxidant is an added trait (Fig. 8).
In-silico molecular simulation through molecular modeling
In order to understand the inhibition mechanism of
Malassezia sp. through Mala s1 allergen by natural com-
pounds primary docking calculations were performed.
The aim of the initial docking was to generate as many
near native complex structures (hits) as possible. About
10 active binding sites were identified based on the
interaction energy between the protein and a simple van
der Waals probe. Figure 9a represents the structure and
binding site of Mala s1 allergen, while Fig. 9b is the
Table 1 Antifungal susceptibility parameters of NAT leaf extract
against Malassezia spp. (μg/μl)
Antifungal
parameters










MIC 1.22 1.47 1.05 1.35
IC50 1.17 1.11 0.74 1.31
MFC 3.12 3.12 3.12 3.12
Fig. 5 Representative linear regression (AUGC) curves for growth of
Malassezia furfur ( short dash; R2 = 0.837), M. restricta ( solid
line; R2 = 0.732), M. globosa ( long dash; R2 = 0.866) and M.
sympodialis ( point dash; R2 = 0.804) as functions of NAT leaf
extract concentration (log transformed)
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cartoon representation of the protein with Site 1 as the
most favorable binding site (obtained from software
server). The volume of Site 1 was estimated to be
685cubic Å and it comprises of 11 residues namely
Asp39, Thr40, Ile41, Tyr42, Leu90, Ser91, Leu92, Leu93,
Thr94, and His95. Following molecular dynamics simu-
lation, the protein Mala s1 allergen with its binding site
in PDB format was loaded to HEX as receptor, while the
natural active constitutes found in NAT leaf extract (β-
Sitosterol and Calceolarioside A) were loaded as ligands
separately. Docking was performed to analyze their bind-
ing conformations. Analysis was based on Etotal or free
energy of binding. For each ligand, number of hits and
total energy calculations, based on shape complementar-
ity, are listed in Table 2 for β-Sitosterol and Table 3 for
Calceolarioside A.
The docking conformation of Cluster 1 of protein with
β-Sitosterol showed Etotal and RMSD values of 283.1
Kcal/mol and -1Kcal/mol. Similarly, Cluster 1 of
Protein-Calceolarioside rated Etotal of 354.9 Kcal/mol
and RMSD of -1 kcal/mol. The docking conformations
of the ligands on the binding site are represented in
Fig. 10a for β-Sitosterol and Fig. 10b for Calceolarioside
A. The ligands were proposed to bind at Site 1 as
predicted by the Qsite finder on specific residues
shown in Fig. 11.
Discussion
Much attention has been given towards the screening of
plant crude extracts and active constituents, but their
mode of action has not been adequately discussed. The
current study, therefore, attempts to delineate the role
of NAT ethanolic extract in modulating the disease eti-
ology caused by Malassezia spp. via its allergen Mala s1
through in-silico molecular simulations.
Since the advent of toxicology, MIC remains the hall-
mark of antimicrobial susceptibility testing but it does
not guarantee success or failure of clinical trials. There-
fore, in-vitro antifungal assay is now used to determine
the development of antifungal susceptibility rather than
the establishment of resistance [39]. This objective was
materialized by turbidimetric measurements of fungal
biomass for the generation of growth curves and other
related parameters under the influence of increasing
concentrations of the extract. The curves of extract free
well demonstrate a lag phase (tlag: the period until the
first detectable change in OD) of 24 h in all species
indiscriminately. Similar durations of tlag were observed
in all tested strains indicating no inter-strain variations
in growth kinetics. Moreover, it could be hypothesized
that the growth patterns in different Malassezia spp. are
regulated by a definite cluster of gene/proteins. When
growth curves in the presence of increasing extract
concentrations were studied, growth parameters were
found to be affected as compared to extract free well. It
could be documented that higher is the drug concentra-
tion, longer is the tlag. Similar observation was made by
Chang et al. [40], while studying the growth curves
based on capacitance in Candida. The presence of drugs
decreased the germination and elongation rates of spores
and germinated spores, respectively, and therefore, the
critical turbidity was reached later, resulting in longer
lag phases.
Since fungal growth kinetics involve long incubation
times, it becomes difficult to estimate the changes in
OD from the start to end point. Therefore, a calculation
model based on AUGC has been developed to study
even small changes of the slope, which might be an indi-
cator of transition between phases. The log phase (tlog)
of the growth curve is that point of the curve where
Fig. 6 In-vitro molecular validation of antifungal susceptibility by PCR analysis. a Genomic DNA amplification of control and treated Malassezia spp.
was performed using primers designed from ITS region and b band intensities of amplicons are presented as volume obtained from VISION-CAPT
software (v14.3). MW represents 100-bp DNA ladder
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AUGC values increase linearly over time and the growth
rate is constant at its highest value [41, 42]. AUGC rep-
resented a strong correlation with the extract concentra-
tions (R2 = 0.837) in M. furfur with about 50 % decrease
in AUGC under highest dose effect as compared to
extract free well. Other species expressed results in
concordance with M. furfur, indicating that the dose
range selected was equally effective over other species
Fig. 7 Sequence density plots showing efficacy of active constituents of NAT leaf extract on lesion of plasma membrane of Malassezia sympodialis
with respective percentages of PI-stained cells. a Untreated control cells, b Cells treated NAT extract at MIC 1.35 μg/μl, c Cells treated with β-Sitosterol
at 0.31 μg/μl, d Cells treated with β-Sitosterol at 0.62 μg/μl, e Cells treated with Calceolarioside A at 0.31 μg/μl, f Cells treated with Calceolarioside A
at 0.62 μg/μl
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under consideration and their growth kinetics in tlog was
also in proximity.
For further determination of quality control of NAT
extract, their MIC range in tested strains was estab-
lished. This was accomplished using sensitive and repro-
ducible spectrophotometrically system rather that
manual visualization. The MIC for M. furfur, M.
restricta, M. globosa, and M. sympodialis extended from
1.05 to 1.47 μg/μl. Percent growth inhibition curves
indicated high correlation values with concentrations. A
linear regression attributed towards strong dose
dependent growth in all fungal strains. Holovachuk et al.
[43] reported an inverse relationship between concentra-
tion of Gentamicin (log transformed) and bacterial
growth based on AUGC. The equation used for the line
was Y = A + B × log(X), where Y = AUGC, A is the y-
intercept, B is the slope of log transformed data and X is
the drug concentration. With reference to the above
analysis, we established a linear relationship between
fungal growth based AUGC and extract concentration
(log transformed). Over the dose range of NAT extract
from 0.02 to 2.5 μg/μl there existed a direct relationship
between drug concentration and the growth phase.
Lower extract concentration did not inhibit growth.
Plotting AUGC against extract concentrations (log trans-
formed) yielded similar findings indicating comparable
working concentration range of the assay for all test
pathogens.
During infection, skin bears a significant fungal load
but with a distinct absence of inflammation. This down
regulation of host inflammatory cascade may be attrib-
uted to the production of the fungal metabolites [44]. In
such conditions the isolation and identification of the
causal organisms and their molecular validation becomes
an important tool for the establishment of pathogenic
conditions of PV. Down regulation in band intensities of
extract treated Malassezia cultures as compared to con-
trol indicated nucleic acid damage thereby depleting fun-
gal population.
Earlier studies have shown that primary mechanism of
action of various antifungal agents is through the disrup-
tion of plasma membranes and interfering with the









Fig. 8 Antioxidant activity of NAT leaf extract of various dose ranges
(0.02–2.5 μg/μl) was treated with DPPH cation to obtain
FRSA spectrophotometrically
Fig. 9 Structure and Binding sites prediction of of Mala s1. a The binding sites are represented in yellow color over the blue background of solid
surface model of Mala s1 allergen and b exhibit specific binding site (blue) of the natural ligand in cartoon representation of Mala s1 allergen (grey).
The sites are analyzed using Q-Site finder server predictions
Table 2 Protein-ligand docking results from HEX server, docked
energies obtained from protein-ligand docking of Mala s1 allergen
of Malassezia spp. with β-Sitosterol
Receptor protein Ligand Cluster Solution Etotal
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normal biosynthetic pathways [45]. This attribute was
studied in terms of PI influx in fungal cells treated with
leaf extract as well as with two active constituents of NAT
by flow cytometry. PI is a membrane-impermeabale fluor-
escent stain that penetrates damaged or permeabilized
plasma membrane and binds to nucleic acid [46]. The
whole plant extract of NAT has been found to disrupt
plasma membrane and facilitate the permeabilization of
PI. Also similar observations have been made with Calceo-
larioside B and β-Sitosterol. These results indicate that
active constituents alter the cell membrane structure,
causing disruption of membrane permeability barrier.
The skin diseases cause disruption of the adjoining
cells and clinically results in skin fragility and blistering.
Therefore, restoring and rejuvenating the skin compo-
nents becomes an important aspect along with the treat-
ment of pathogens. In this aspect antioxidants play a
vital role and constitute an integral component of
Table 3 Protein-ligand docking results from HEX server, docked
energies obtained from protein-ligand docking of Mala s1 allergen
of Malassezia spp. with Calceolarioside A
Receptor protein Ligand Cluster Solution Etotal










Fig. 10 Protein-ligand docking conformation. The Protein Mala s1 allergen of Malassezia sympodialis is represented in blue solid surface model
with yellow binding pockets. a The ligand β-Sitosterol represented in licorice form is embedded in the binding pocket. The binding mode as
predicted by the docking program HEX (6.12v) gives an Etotal of −283.03 (left). The docked sites are also represented as an enlarged view (right).
b The ligand Calseolarioside A represented in licorice form is embedded in the binding pocket. The binding mode as predicted by the docking
program HEX (6.12v) gives an Etotal of −354.93 (right). The docked sites are also represented as an enlarged view (right)
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topical ointments. Recent studies have shown that the
leaves and stem of Nyctanthes arbor-tristis are a poten-
tial source of natural antioxidants [47]. Ethanolic ex-
tracts of leaves and stem contains secondary metabolites
of several classes viz., flavonoids, tannins, saponins,
glycosides, alkaloids, steroids and phenolic compounds,
of which phenolic compounds are also responsible for
its antioxidant activity [48, 49]. The antioxidant activity
in form of percent inhibition of DPPH radical showed a
uniform increase with the increase in the concentration
of the extract. Since inflammation and oxidative stress
appear to play a significant role in Pityriasis versicolor,
leaves of NAT may play an important role in wound
healing through its antioxidant capacity facilitating free
radicals scavenging thereby down regulating skin inflam-
mation. Thus, the antioxidant potential marks an added
advantage in the treatment of skin inflammation.
Mechanisms of action studies of natural molecules are
fundamental to drug discovery. However, in-vitro studies
alone may not recapitulate compound’s MoA in whole
cell. Therefore, with the establishment of anti-Malassezia
capacity of NAT in-vitro, we employed in-silico modeling
of Mala s1 allergen of M. sympodialis with the bioactive
constituents from NAT. Genes encoding for all 10 aller-
gens previously cloned in different species of Malassezia,
are now reported to exist in M. sympodialis genome [50].
Thus, in the current study, we addressed Mala s1 allergen
of M. sympodialis (PDB ID: 2P9W) as a model to advance
our understanding of how the yeasts interact with the host
and contributes to disease pathogenesis. The localization
of Mala s1 on the cell surface [51] and its role in disease
etiology merits the background and frame of further in-
vestigations. Further, docking was performed between
protein and active molecules (β-Sitosterol and
Calceolarioside A) using Hex server and their interaction
energies were analyzed (Tables 2 and 3). The low energies
ensured efficient docking and also revealed that the
protein could form hydrogen bond networks involving
various active amino acid residues [52]. Figure 11 reveals
various residues that exclusively contribute towards the
binding of the protein with the natural molecules. Cumu-
latively, the evidence leads us to propose that the potent
inhibition of cell surface allergen Mala s1 by the active
constituents of NAT makes the later a unique and useful
tool among the pre-existing synthetic antifungals. How-
ever, it is tempting to validate the sub-cellular machinery
that will further enlighten the stage to identify new targets
and their cognate inhibitors for development of novel
antifungal therapeutics.
Conclusion
The findings stated above provide an insight about the
medicinal impact of NAT leaf ethanolic extract that has
an inhibitory effect over Malassezia spp. The growth
curves and the related parameters indicate that the ex-
tract can be used against different strains of Malassezia
spp. The fungal DNA depletion associated with extract
treatment also signifies the therapeutic potential of the
extract. The disruption of cell membrane as observed by
flow cytometry further confirms the role of active
constituents as antifungal agents by driving membrane-
active mechanism. Moreover, in-silico prediction identi-
fied specific binding sites on Mala s1 allergen that could
be useful for structure-based drug designing. Further,
the virtual screening of two active constituents from
NAT leaf extract and their efficient docking with
Mala s1 open up new avenues for the development of
plant based antifungal formulations for skin care after
Fig. 11 Detailed representations of binding residues of Mala s1 allergen with a β-Sitosterol and b Calceolarioside A. Mala s1 is represented in
chain form with binding sites in mesh form (green). The residues were identified using Atom Picking mode of docking software HEX
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generating toxicological data as well as successful
topical testing.
Availability of data and materials
The chemical structures of the active constituents were
obtained from http://pubchem.ncbi.nlm.nih.gov/. The
crystal structure of protein was obtained from http://
www.rcsb.org.
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